US Patent 7399771 Piperidine derivatives as CCR5 inhibitors
Patent 7399771 was granted and assigned to Novartis on July, 2008 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 6, 2003
0
Date of Patent
July 15, 2008
0
Patent Application Number
10529776
0
Patent Inventor Names
Rainer Albert
0
Hans-Günter Zerwes
0
Markus Streiff
0
Nigel Graham Cooke
0
Christian Bruns
0
François Nuninger
0
Gebhard Thoma
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7399771 Piperidine derivatives as CCR5 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
